Free tool
GDOC and PHSYX: how much do they overlap?
Enter any two ETFs or mutual funds to see how much of their portfolios overlap, using each fund's latest SEC holdings report.
Bottom line
Overlap between GDOC and PHSYX
54% of their top holdings overlap by weight, with 11 securities in common among each fund's top 25. They share a meaningful core but differ in the rest of the portfolio. Note that PHSYX holds far more positions (115 vs 42), so it is broader beyond the top names.
| Holding | % of GDOC | % of PHSYX |
|---|---|---|
| Eli Lilly & Company | 13.28% | 13.15% |
| Johnson & Johnson | 8.07% | 8.46% |
| Merck & Company Inc | 5.94% | 4.88% |
| Astrazeneca Plc | 4.84% | 4.67% |
| Thermo Fisher Scientific Inc | 4.52% | 4.50% |
| Intuitive Surgical Inc | 3.90% | 4.04% |
| Boston Scientific Corp | 3.78% | 1.80% |
| Hoya Corp | 3.53% | 1.52% |
| Edwards Lifesciences Corp | 2.98% | 2.80% |
| Dexcom Inc | 2.79% | 1.64% |
| Vertex Pharmaceuticals Inc | 1.48% | 1.97% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Popular overlap checks
| Pair | Overlap | |
|---|---|---|
| VOO vs VTI | 99% | Details |
| QQQ vs VGT | 57% | Details |
| SCHD vs VYM | 24% | Details |
| VOO vs QQQ | 68% | Details |
| VTI vs VXUS | 0% | Details |
| VUG vs QQQ | 69% | Details |
| JEPI vs SCHD | 2% | Details |
Source: SEC Form N-PORT; top-25 holdings, weight-normalized